scholarly article | Q13442814 |
P50 | author | Michal Schwartz | Q21264411 |
Ninette Amariglio | Q106204024 | ||
Anat London | Q120600405 | ||
Ravid Shechter | Q125288906 | ||
Asya Rolls | Q37834540 | ||
P2093 | author name string | Jasmin Jacob-Hirsch | |
Yifat Segev | |||
Gidon Rechavi | |||
P2860 | cites work | LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia | Q24685951 |
Regeneration beyond the glial scar | Q28239915 | ||
Reactive astrocytes protect tissue and preserve function after spinal cord injury | Q28248202 | ||
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms | Q29547835 | ||
Chondroitinase ABC promotes functional recovery after spinal cord injury | Q29615017 | ||
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids | Q29616817 | ||
Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion | Q29618089 | ||
Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. | Q33198766 | ||
Spinal cord repair: strategies to promote axon regeneration | Q34132350 | ||
Repulsive factors and axon regeneration in the CNS. | Q34141473 | ||
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy | Q34486849 | ||
Plasticity following lesion: help and harm from the immune system. | Q34704770 | ||
The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis | Q34831062 | ||
Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury | Q35090882 | ||
Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis | Q35094527 | ||
Brain repair and neuroprotection by serum insulin-like growth factor I. | Q35141396 | ||
Anti-inflammatory effects of heparin and its derivatives: inhibition of complement and of lymphocyte migration | Q35533559 | ||
Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays | Q35548578 | ||
Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages | Q35609982 | ||
Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease | Q35789671 | ||
How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes | Q35842732 | ||
Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. | Q50726567 | ||
Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. | Q51204340 | ||
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. | Q52512624 | ||
Activation of microglial cells by beta-amyloid protein and interferon-gamma. | Q53202007 | ||
Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. | Q55067631 | ||
T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS | Q57090609 | ||
Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system | Q68543538 | ||
IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase | Q77186261 | ||
Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia | Q79180789 | ||
New GABAergic interneurons supported by myelin-specific T cells are formed in intact adult spinal cord | Q80412164 | ||
Chondroitin sulfate in palatal wound healing | Q80908295 | ||
Microglia | Q81034804 | ||
Microglia and neuroprotection: implications for Alzheimer's disease | Q81683788 | ||
Proteoglycans and injury of the central nervous system | Q35964844 | ||
Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease | Q36402221 | ||
Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury | Q36402894 | ||
Molecular and cellular immune mediators of neuroprotection | Q36739426 | ||
Neuroprotective role of the innate immune system by microglia | Q36801872 | ||
Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury | Q37138010 | ||
Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. | Q37471962 | ||
The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro | Q40119262 | ||
Microglia provide neuroprotection after ischemia | Q40317498 | ||
A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. | Q40318758 | ||
Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. | Q40470094 | ||
Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. | Q40482519 | ||
Chondroitin sulfate proteoglycan with neurite-inhibiting activity is up-regulated following peripheral nerve injury | Q42450980 | ||
Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury | Q42606175 | ||
Autoreactive T cells promote post-traumatic healing in the central nervous system. | Q42691926 | ||
White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis | Q43838103 | ||
Macrophage-derived factors stimulate optic nerve regeneration. | Q44376583 | ||
Concentration-dependent actions of glial chondroitin sulfate on the neuritic growth of midbrain neurons | Q44414248 | ||
A disaccharide derived from chondroitin sulphate proteoglycan promotes central nervous system repair in rats and mice | Q45079445 | ||
NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. | Q46345563 | ||
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions | Q46891042 | ||
Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury. | Q48267170 | ||
Triggering the brain's pathology sensor. | Q48357297 | ||
Differential effects of Th1 and Th2 lymphocyte supernatants on human microglia | Q48384113 | ||
The cellular inflammatory response in human spinal cords after injury | Q48384322 | ||
IGF-I and microglia/macrophage proliferation in the ischemic mouse brain | Q48552439 | ||
Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules | Q48558550 | ||
Morphology of reactive microglia in the injured cerebral cortex. Fractal analysis and complementary quantitative methods | Q48623708 | ||
Spatial and temporal changes in the insulin-like growth factor (IGF) axis indicate autocrine/paracrine actions of IGF-I within wounds of the rat brain | Q48677755 | ||
Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. | Q48691176 | ||
'Semifree-floating' treatment: a simple and fast method to process consecutive sections for immunohistochemistry and neuronal tracing | Q48774819 | ||
Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord | Q48819305 | ||
Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. | Q48824436 | ||
Regenerative failure: a potential mechanism for neuritic dystrophy in Alzheimer's disease | Q48880786 | ||
Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures | Q48973809 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | macrophage | Q184204 |
microglia | Q1622829 | ||
P304 | page(s) | e171 | |
P577 | publication date | 2008-08-19 | |
P1433 | published in | PLOS MEDICINE | Q1686921 |
P1476 | title | Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation | |
P478 | volume | 5 |
Q38793073 | "Targeting astrocytes in CNS injury and disease: A translational research approach". |
Q40104988 | 2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination. |
Q92370548 | 2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions |
Q37261081 | A pilot study of poly(N-isopropylacrylamide)-g-polyethylene glycol and poly(N-isopropylacrylamide)-g-methylcellulose branched copolymers as injectable scaffolds for local delivery of neurotrophins and cellular transplants into the injured spinal cor |
Q28392297 | ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease |
Q31122599 | Ablation of keratan sulfate accelerates early phase pathogenesis of ALS. |
Q33969817 | Abrogation of β-catenin signaling in oligodendrocyte precursor cells reduces glial scarring and promotes axon regeneration after CNS injury. |
Q28744661 | Activated microglia inhibit axonal growth through RGMa |
Q37128209 | Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents |
Q39821138 | Alterations of protein composition along the rostro-caudal axis after spinal cord injury: proteomic, in vitro and in vivo analyses |
Q36092501 | An overview of pharmacological approaches for management and repair of spinal cord injuries |
Q38966132 | Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases |
Q36554467 | Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells |
Q37693739 | Bridging the Divide between Neuroprosthetic Design, Tissue Engineering and Neurobiology |
Q45376613 | CNS repair requires both effector and regulatory T cells with distinct temporal and spatial profiles |
Q82901089 | Chondroitin beta-1,4-N-acetylgalactosaminyltransferase-1 missense mutations are associated with neuropathies |
Q39266450 | Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. |
Q37196329 | Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment. |
Q34282030 | Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury |
Q46177334 | Comment on "chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination". |
Q36090107 | Demyelination as a rational therapeutic target for ischemic or traumatic brain injury |
Q93140446 | Detecting the long non‑coding RNA signature related to spinal cord ependymal tumor subtype using a genome‑wide methylome analysis approach |
Q33488236 | Differential expression of receptor protein tyrosine phosphatases accompanies the reorganisation of the retina upon laser lesion |
Q49397380 | Environmental cues determine the fate of astrocytes after spinal cord injury |
Q47388453 | Epothilone B impairs functional recovery after spinal cord injury by increasing secretion of macrophage colony-stimulating factor |
Q34414830 | Examination of the combined effects of chondroitinase ABC, growth factors and locomotor training following compressive spinal cord injury on neuroanatomical plasticity and kinematics |
Q33906928 | Extracellular matrix regulation of inflammation in the healthy and injured spinal cord |
Q48385724 | Extrinsic and intrinsic factors controlling axonal regeneration after spinal cord injury |
Q93083711 | Facile saccharide-free mimetics that recapitulate key features of glycosaminoglycan sulfation patterns |
Q38366783 | From demyelination to remyelination: the road toward therapies for spinal cord injury |
Q27024453 | Function of microglia and macrophages in secondary damage after spinal cord injury |
Q36765022 | Functional macrophage heterogeneity in a mouse model of autoimmune central nervous system pathology |
Q38206485 | Glial scar and immune cell involvement in tissue remodeling and repair following acute CNS injuries |
Q39181869 | Glial scar-modulation as therapeutic tool in spinal cord injury in animal models. |
Q38046114 | Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. |
Q27308097 | Hematogenous macrophage depletion reduces the fibrotic scar and increases axonal growth after spinal cord injury |
Q26995364 | How do immune cells support and shape the brain in health, disease, and aging? |
Q92330636 | Identification and characterization of microglia/macrophages in the granuloma microenvironment of encephalic schistosomiasis japonicum |
Q55253477 | Identification of a critical sulfation in chondroitin that inhibits axonal regeneration. |
Q46387484 | Immunobiology of spinal cord injuries and potential therapeutic approaches |
Q37310621 | Immunomodulatory and anti-inflammatory effects of chondroitin sulphate |
Q38226802 | In the presence of danger: The extracellular matrix defensive response to central nervous system injury. |
Q27307172 | Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice |
Q57599442 | Innate Immunity in the CNS - A Focus on the Myeloid Cell |
Q48258249 | Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin-N-cadherin pathway after spinal cord injury |
Q52145462 | Lack of NG2 exacerbates neurological outcome and modulates glial responses after traumatic brain injury. |
Q64054986 | Macrophage centripetal migration drives spontaneous healing process after spinal cord injury |
Q38193884 | Macrophages and CNS remyelination |
Q53180449 | Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury. |
Q39833593 | Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair |
Q89810267 | Microglia control vascular architecture via a TGFβ1 dependent paracrine mechanism linked to tissue mechanics |
Q35394922 | Microglial and macrophage polarization—new prospects for brain repair |
Q37983759 | Microglial carbohydrate-binding receptors for neural repair. |
Q39852498 | Monocyte-Derived Macrophages Contribute to Spontaneous Long-Term Functional Recovery after Stroke in Mice. |
Q39388337 | Myeloid Cells in the Central Nervous System |
Q50626932 | Myeloid-Specific Blockade of Notch Signaling by RBP-J Knockout Attenuates Spinal Cord Injury Accompanied by Compromised Inflammation Response in Mice. |
Q55082031 | Neural crest stem cells protect spinal cord neurons from excitotoxic damage and inhibit glial activation by secretion of brain-derived neurotrophic factor. |
Q26995185 | Neural stem cell niches in health and diseases |
Q94311674 | Neuronal injury and repair: for glial scar protein, timing is everything |
Q34501419 | Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. |
Q48311249 | Newly Formed Endothelial Cells Regulate Myeloid Cell Activity Following Spinal Cord Injury via Expression of CD200 Ligand |
Q48098141 | Overcoming neurite-inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix. |
Q30238775 | Overview of Traumatic Brain Injury: An Immunological Context |
Q38132334 | Pathophysiology of the brain extracellular matrix: a new target for remyelination. |
Q90248349 | Pericytes Act as Key Players in Spinal Cord Injury |
Q53412902 | Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia. |
Q52646465 | Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury. |
Q35729506 | Phenotypic assays to identify agents that induce reactive gliosis: a counter-screen to prioritize compounds for preclinical animal studies |
Q38017625 | Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. |
Q28389274 | Reciprocal modulation between microglia and astrocyte in reactive gliosis following the CNS injury |
Q33839440 | Regional heterogeneity in astrocyte responses following contusive spinal cord injury in mice |
Q53254561 | Regulation of chondroitin sulphate proteoglycan and reactive gliosis after spinal cord transection: effects of peripheral nerve graft and fibroblast growth factor 1. |
Q37492253 | Regulation of innate immune responses in the brain |
Q30424827 | Regulatory T cells in CNS injury: the simple, the complex and the confused |
Q57031212 | Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma |
Q34168279 | Role of microglia in neurotrauma |
Q48148010 | Sex differences in glia reactivity after cortical brain injury. |
Q88538756 | Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses |
Q37833644 | Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages |
Q28394140 | Stem cell therapy for central nerve system injuries: glial cells hold the key |
Q39236820 | Sulfated glycosaminoglycans in protein aggregation diseases |
Q28741573 | Syndromics: a bioinformatics approach for neurotrauma research |
Q34798895 | Targeted downregulation of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase significantly mitigates chondroitin sulfate proteoglycan-mediated inhibition |
Q92565165 | Targeting the Chondroitin Sulfate Proteoglycans: Evaluating Fluorinated Glucosamines and Xylosides in Screens Pertinent to Multiple Sclerosis |
Q85258862 | Temporal and spatial expression of KIF3B after acute spinal cord injury in adult rats |
Q37346515 | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance |
Q36686413 | The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice |
Q52669755 | The Biology of Regeneration Failure and Success After Spinal Cord Injury. |
Q38691715 | The Role of Decidual Macrophages During Normal and Pathological Pregnancy |
Q42562079 | The association between laminin and microglial morphology in vitro. |
Q37396812 | The bright side of the glial scar in CNS repair |
Q88230827 | The extracellular matrix: Focus on oligodendrocyte biology and targeting CSPGs for remyelination therapies |
Q38122112 | The glial scar in spinal cord injury and repair |
Q27311808 | The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair |
Q92721012 | The origin, fate, and contribution of macrophages to spinal cord injury pathology |
Q36520580 | The reactions and role of NG2 glia in spinal cord injury |
Q38758872 | The regenerative effects of electromagnetic field on spinal cord injury |
Q43873599 | The regulatory peptide pidotimod facilitates M2 macrophage polarization and its function |
Q38061012 | The retina as a window to the brain-from eye research to CNS disorders |
Q36954609 | The retinal pigment epithelium as a gateway for monocyte trafficking into the eye. |
Q37295387 | Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis |
Q54035553 | Towards personalized cell-replacement therapies for brain repair. |
Q48852948 | Transplantation of Schwann cells differentiated from adipose-derived stem cells modifies reactive gliosis after contusion brain injury in rats |
Q64061191 | Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms |
Q33748201 | Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis |
Q39788151 | γ-Secretase component presenilin is important for microglia β-amyloid clearance. |
Search more.